mechlorethamine has been researched along with Immunoblastic Lymphadenopathy in 3 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Immunoblastic Lymphadenopathy: A disorder characterized by proliferation of arborizing small vessels, prominent immunoblastic proliferations and amorphous acidophilic interstitial material. Clinical manifestations include fever, sweats, weight loss, generalized lymphadenopathy and frequently hepatosplenomegaly.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lazza, M | 1 |
| Ramella, G | 1 |
| Cianferoni, MF | 1 |
| Rognoni, M | 1 |
| Bevilacqua, M | 1 |
| Cazzola, M | 1 |
| Bergamaschi, G | 1 |
| Castello, A | 1 |
| Del Forno, C | 1 |
| Dezza, L | 1 |
| Magrini, U | 1 |
| Ascari, E | 1 |
| Ganesan, TS | 1 |
| Dhaliwal, HS | 1 |
| Dorreen, MS | 1 |
| Stansfeld, AG | 1 |
| Habeshaw, JA | 1 |
| Lister, TA | 1 |
3 other studies available for mechlorethamine and Immunoblastic Lymphadenopathy
| Article | Year |
|---|---|
[A case of angioimmunoblastic lymphadenopathy with dysproteinemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Protein Disorders; Child; Humans; Immunoblasti | 1982 |
Kaposi's sarcoma complicating immunosuppressive therapy for angioimmunoblastic lymphadenopathy with dysproteinemia.
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combinati | 1982 |
Angio-immunoblastic lymphadenopathy: a clinical, immunological and molecular study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Female; Humans | 1987 |